News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Eduardo Terán: Disappointing results from the Phase 2 INNOVATION trial
Eduardo Terán/X
Jan 25, 2025, 12:41

Eduardo Terán: Disappointing results from the Phase 2 INNOVATION trial

Eduardo Terán, GI Medical Oncologist at Vall d’Hebron Barcelona Hospital, posted on X:

“Disappointing results from the Phase 2 INNOVATION trial, maybe FLOT-T is a well tolerated option to improve tumor downsizing for surgery…

Brilliant discussion by Dr. Yoon on pCR and HER2 challenges in resectable GEA.”

Eduardo Terán: Disappointing results from the Phase 2 INNOVATION trial

ASCO GI 2025 cancer Eduardo Terán INNOVATION trial OncoDaily Oncology
Special Coverage
Science
Feb 27, 2025, 17:56
Jasmine Kamboj: We need realistic and sustainable expectations of oncologists
Blog
Feb 27, 2025, 17:55
Jean Bustamante Alvarez: I’m starting a new position at Jacobi Medical Center
Blog
Feb 27, 2025, 17:54
European Cancer Summit 2024 Report is out - European Cancer Organisation
Blog
Feb 27, 2025, 17:53
Sahar Mansour: A Proud Moment for Interventional Radiology in Egypt
Blog
Feb 27, 2025, 17:49
C. Ola Landgren: Register now for the annual Miami Myeloma MRD Meeting
Blog
Feb 27, 2025, 17:46
Estela Rodriguez: Nominate yourself or a colleague for an IASLC committee
Science
Feb 27, 2025, 17:42
Loay Kassem: Breast saving surgery without radiotherapy could be the new standard for EBC
Blog
Feb 27, 2025, 17:16
Ruzanna Papyan: Exclusive Educational Session on Immune Landscape of Neuroblastoma
Blog
Feb 27, 2025, 17:13
Submission deadline is approaching for the late-breaker abstracts for MASCC25
Blog
Feb 27, 2025, 17:10
Fertility Preservation Is Key in Survivorship - Childhood Cancer International
Blog
Feb 27, 2025, 17:01
Chris Boshoff: Pfizer has entered into a clinical trial collaboration with Summit Therapeutics
Blog
Feb 27, 2025, 16:55
Daniel De Carvalho: Chronic viral mimicry after p53 loss enables immune evasion in early ovarian cancer